Deep neural network modeling for brain tumor classification using magnetic resonance spectroscopic imaging.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40202966.
- Also identified by DOI 10.1371/journal.pdig.0000784 and PMC identifier 11981170.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This study is driven by the complex and specialized nature of magnetic resonance spectroscopy imaging (MRSI) data processing, particularly within the scope of brain tumor assessments. Traditional methods often involve intricate manual procedures that demand considerable expertise. In response, we investigate the application of deep neural networks directly to raw MRSI data in the time domain. Given the significant health risks associated with brain tumors, the necessity for early and accurate detection is crucial for effective treatment. While conventional MRI techniques encounter limitations in the rapid and precise spatial evaluation of diffuse gliomas, both accuracy and efficiency are often compromised. MRSI presents a promising alternative by providing detailed insights into tissue chemical composition and metabolic changes. Our proposed model, which utilizes deep neural networks, is specifically designed for the analysis and classification of spectral time series data. Trained on a dataset that includes both synthetic and real MRSI data from brain tumor patients, the model aims to distinguish MRSI voxels that indicate pathological conditions from healthy ones. Our findings demonstrate the model's robustness in classifying glioma-related MRSI voxels from those of healthy tissue, achieving an area under the receiver operating characteristic curve of 0.95. Overall, these results highlight the potential of deep learning approaches to harness raw MR data for clinical applications, signaling a transformative impact on diagnostic and prognostic assessments in brain tumor examinations. Ongoing research is focused on validating these approaches across larger datasets, to establish standardized guidelines and enhance their clinical utility.